• Dartmouth TTO

READ: "Mosaic ImmunoEngineering Inc. signs license-option to advance novel immunotherapy..."

Mosaic ImmunoEngineering Inc., a private biotechnology company based in Novato, California, has signed a two-year option agreement with Case Western Reserve University and Dartmouth College, granting the company the exclusive right to license the technology for a novel platform technology using virus-like nanoparticles (“VLP”) to treat and prevent cancer and infectious diseases in humans and for veterinary use.

Read the article HERE.

42 views0 comments

Recent Posts

See All